中华神经科杂志
中華神經科雜誌
중화신경과잡지
Chinese Journal of Neurology
2010年
7期
512-515
,共4页
孙莉%徐艳炜%梁浩%孙国敏%程焱
孫莉%徐豔煒%樑浩%孫國敏%程焱
손리%서염위%량호%손국민%정염
脑缺血%再灌注损伤%PPARγ
腦缺血%再灌註損傷%PPARγ
뇌결혈%재관주손상%PPARγ
Brain ischemia%Reperfusion injury%PPAR gamma
目的 观察过氧化物酶体增殖物激活受体γ(PPARγ)在脑缺血再灌注损伤中核移位的改变,并初步探讨该改变在脑缺血损伤中的意义.方法 健康雄性SD大鼠制作大脑中动脉阻塞再灌注模型,缺血60 min,再灌注4、8、24 h.采用Western blot法、免疫组织化学和免疫荧光染色法观察PPARγ核移位的改变以及PPARγ激动剂和拮抗剂对PPARγ核移位的影响;同时,2,3,5-氯化三苯四唑(TTC)染色法观察脑梗死体积的改变.结果 (1)Western blot检测显示,脑缺血再灌注4 h即引起PPARγ核蛋白增加,同时胞质蛋白减少,差异具有统计学意义.随再灌注时间的增加,PPARγ核移位呈时间依赖性增强.免疫组织化学和免疫荧光染色均显示,与假手术组48.3%相比,缺血再灌注24 h胞核PPARγ阳性增加到80.3%,差异具有统计学意义(t=8.63,P=0.00).(2)与单纯缺血再灌注组相比,PPARγ激动剂进一步增加PPARγ核蛋白表达,同时减少胞质蛋白表达,差异均具有统计学意义;相反,PPARγ抑制剂GW9662则降低核蛋白水平而增加胞质表达,差异均具有统计学意义.(3)经TTC染色显示,与单纯缺血再灌注组相比,PPARγ激动剂使脑梗死体积减少了48.40%(15.46±4.94与29.96 ±3.39,t=5.93,P=0.00);而PPARγ抑制剂则使脑梗死体积增加了58.95%(47.62±4.93与29.96±3.39,t=7.23,P=0.00).结论 脑缺血再灌注损伤使大鼠PPARγ核移位增加,该改变可能是脑组织的一种自我保护性反应.
目的 觀察過氧化物酶體增殖物激活受體γ(PPARγ)在腦缺血再灌註損傷中覈移位的改變,併初步探討該改變在腦缺血損傷中的意義.方法 健康雄性SD大鼠製作大腦中動脈阻塞再灌註模型,缺血60 min,再灌註4、8、24 h.採用Western blot法、免疫組織化學和免疫熒光染色法觀察PPARγ覈移位的改變以及PPARγ激動劑和拮抗劑對PPARγ覈移位的影響;同時,2,3,5-氯化三苯四唑(TTC)染色法觀察腦梗死體積的改變.結果 (1)Western blot檢測顯示,腦缺血再灌註4 h即引起PPARγ覈蛋白增加,同時胞質蛋白減少,差異具有統計學意義.隨再灌註時間的增加,PPARγ覈移位呈時間依賴性增彊.免疫組織化學和免疫熒光染色均顯示,與假手術組48.3%相比,缺血再灌註24 h胞覈PPARγ暘性增加到80.3%,差異具有統計學意義(t=8.63,P=0.00).(2)與單純缺血再灌註組相比,PPARγ激動劑進一步增加PPARγ覈蛋白錶達,同時減少胞質蛋白錶達,差異均具有統計學意義;相反,PPARγ抑製劑GW9662則降低覈蛋白水平而增加胞質錶達,差異均具有統計學意義.(3)經TTC染色顯示,與單純缺血再灌註組相比,PPARγ激動劑使腦梗死體積減少瞭48.40%(15.46±4.94與29.96 ±3.39,t=5.93,P=0.00);而PPARγ抑製劑則使腦梗死體積增加瞭58.95%(47.62±4.93與29.96±3.39,t=7.23,P=0.00).結論 腦缺血再灌註損傷使大鼠PPARγ覈移位增加,該改變可能是腦組織的一種自我保護性反應.
목적 관찰과양화물매체증식물격활수체γ(PPARγ)재뇌결혈재관주손상중핵이위적개변,병초보탐토해개변재뇌결혈손상중적의의.방법 건강웅성SD대서제작대뇌중동맥조새재관주모형,결혈60 min,재관주4、8、24 h.채용Western blot법、면역조직화학화면역형광염색법관찰PPARγ핵이위적개변이급PPARγ격동제화길항제대PPARγ핵이위적영향;동시,2,3,5-록화삼분사서(TTC)염색법관찰뇌경사체적적개변.결과 (1)Western blot검측현시,뇌결혈재관주4 h즉인기PPARγ핵단백증가,동시포질단백감소,차이구유통계학의의.수재관주시간적증가,PPARγ핵이위정시간의뢰성증강.면역조직화학화면역형광염색균현시,여가수술조48.3%상비,결혈재관주24 h포핵PPARγ양성증가도80.3%,차이구유통계학의의(t=8.63,P=0.00).(2)여단순결혈재관주조상비,PPARγ격동제진일보증가PPARγ핵단백표체,동시감소포질단백표체,차이균구유통계학의의;상반,PPARγ억제제GW9662칙강저핵단백수평이증가포질표체,차이균구유통계학의의.(3)경TTC염색현시,여단순결혈재관주조상비,PPARγ격동제사뇌경사체적감소료48.40%(15.46±4.94여29.96 ±3.39,t=5.93,P=0.00);이PPARγ억제제칙사뇌경사체적증가료58.95%(47.62±4.93여29.96±3.39,t=7.23,P=0.00).결론 뇌결혈재관주손상사대서PPARγ핵이위증가,해개변가능시뇌조직적일충자아보호성반응.
objective To examine nuclear transIocation of peroxisome proliferator-activated receptor γ(PPARγ)in rats following focal cerebral ischemia/reperfusion(I/R),and to explore the significance of altered PPARγ,nuclear translocation in ischemic brain injury.Methods Healthy adult male SD rats underwent 60-min cerebral artery occlusion followed by reperfusion of 4,8,or 24 h,respectively.The cytoplasmic-to-nuclear shuttling of PPARγ was characterized by Western blot,immunohistochemical and immunofluoreseence staining.The effects of PPARγ agonist rosiglitazone (Ros) and antagonist GW9662 on I/R-induced PPARγ nuclear translocation were also examined in the present study. Furthermore,TTC staining war adopted to determine the change in cerebral infarction volume. Results (1)Western blot analysis revealed an increase of PPARγ in the nucleus and a simultaneous reduction in the cytosol following ischemia and reperfusion for 4 h(tcytosol=9.03,tmuclear=27.19,P=0.00).Prolonged the reperfusion further enhanced this I/R induced PPARγ translocation in a time-dependent manner.Using immunohistochemistry and immunofluorescence,nuclear PPAR γ positive staining increased from 48.3%in the sham control to 80.3% following ischemia and reperfusion for 24 h.(2)Western blot analysis revealed that PPARγ agonist Ros further increased I/R-induced nuclear enrichment of PPARγ,whereas PPARγ antagonist GW9662inhibited I/R-stimulated change in PPARγ.(3)When compared to the L/R group using TTC staining,Ros treatment significantly decreased the infarction volume by 48.40%(15.46±4.94 versus 29.96±3.39,t=5.93.P=0.00),whereas GW9662 increased by 58.95%(47.62±4.93 versus 29.96±3.39,t=7.23,P=0.00).Conclusions Cerebral I/R injury induces PPARγ translocation from the cytosol to the nucleus.This change may represent an intrinsic neuroprotective response against brain I/R injury.